Restarting RA Therapy After a Treatment Disruption
Rheumatology
Curriculum:
Managing a Non-Responder to Methotrexate
Managing a Non-Responder to Methotrexate
Credits:
0.75 ANCC Contact Hours 1 CA-BRN Credit(s) 0.75 AMA PRA Category 1 Credit(s) ™
0.75 ANCC Contact Hours 1 CA-BRN Credit(s) 0.75 AMA PRA Category 1 Credit(s) ™
Launch Date:
June 14, 2013
June 14, 2013
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Rheumatologists, Rheumatology Nurses
Relevant Terms:
Rheumatology
Neal Birnbaum, MD, FACP, MACR
Neal Birnbaum, MD, FACP, MACR
Director, Division of Rheumatology
California Pacific Medical Center
San Francisco, CA
Bio
Neal Birnbaum, MD, FACP, MACR, is Director of the Division of Rheumatology at California Medical Center and Clinical Professor of Medicine at the University of California San Francisco. He also has a private rheumatology practice in San Francisco. He has served as Chief of Staff of the San Francisco Medical Society, and been Chief of Staff at California Pacific Medical Center.
Dr. Birnbaum completed medical school at Ohio State University, graduating Cum Laude. He completed a fellowship in Rheumatology and residency in Internal Medicine at the University of Pittsburgh School of Medicine. His clinical skills have been recognized by his inclusion in every edition of The Best Doctors in America. In addition, he has been active in the American College of Rheumatology (ACR) for many years, serving as past ACR president. He is also past president of the California Society of Internal Medicine and a Fellow of the American College of Physicians.
Dr. Birnbaum has been Vice-chairman for Medical Affairs of the northern California chapter of the Arthritis Foundation and was a founding board member of the Scleroderma Research Foundation. He also assumed an additional role as board chairperson of Brown and Toland Medical Group. He recently co-authored a book for patients, The Complete Idiot's Guide to Arthritis. He was named an ACR Master in 2011. His work has been published in peer-reviewed journals including Arthritis & Rheumatism and Drug Benefit Trends.
Dr. Birnbaum completed medical school at Ohio State University, graduating Cum Laude. He completed a fellowship in Rheumatology and residency in Internal Medicine at the University of Pittsburgh School of Medicine. His clinical skills have been recognized by his inclusion in every edition of The Best Doctors in America. In addition, he has been active in the American College of Rheumatology (ACR) for many years, serving as past ACR president. He is also past president of the California Society of Internal Medicine and a Fellow of the American College of Physicians.
Dr. Birnbaum has been Vice-chairman for Medical Affairs of the northern California chapter of the Arthritis Foundation and was a founding board member of the Scleroderma Research Foundation. He also assumed an additional role as board chairperson of Brown and Toland Medical Group. He recently co-authored a book for patients, The Complete Idiot's Guide to Arthritis. He was named an ACR Master in 2011. His work has been published in peer-reviewed journals including Arthritis & Rheumatism and Drug Benefit Trends.
Vivian Bykerk, MD
Vivian Bykerk, MD
Assistant Attending Rheumatologist
Hospital for Special Surgery
New York, NY
Bio
Dr. Vivian Bykerk is a member of a team of specialists at the Inflammatory Arthritis Center at Hospital for Special Surgery. The Center includes a dedicated inflammatory arthritis clinic, extensive arthritis registries, scientific studies focused on musculoskeletal and autoimmune diseases, a physician education program, and most importantly, an emphasis on providing quality health care to patients.
Dr. Bykerk brings an extensive knowledge base and experience in rheumatology. She completed a residency in Internal Medicine at Mount Sinai Hospital in Toronto, Ontario, Canada, and spent two years as a Rheumatology Fellow at McGill University, in Montreal, Quebec. Dr. Bykerk received the Senior Rheumatology Scholar Award in 1989 presented by the American College of Rheumatology for her research in lupus. She served as the Director of the Early Arthritis Program at Mount Sinai Hospital, Toronto, Ontario, Canada and comes to Hospital for Special Surgery from Brigham & Women's Hospital, Boston, where she was in the Division of Rheumatology. She has been in rheumatology practice for over 20 years.
Jacqueline Fritz, RN, MSN, CNS
Jacqueline Fritz, RN, MSN, CNS
Medical Advancement Center
Critical Care and Rheumatology Specialist
Cypress, California
Bio
Jacqueline Fritz, RN, MSN, CNS, is owner and Coordinator of Education at the Medical Advancement Center in Cypress, CA, where she teaches RN/BSN programs at various facilities. She is also a Critical Care Clinical Nurse Consultant to many acute care facilities in the California area, such as Cigna, Arcadia Methodist, and Doctor's Hospital of Lakewood. She is also an ACLS affiliate and West Coast Regional Director responsible for training and supervising ACLS courses in Los Angeles and Orange County.
| 1. | Implement evidence-based guidelines into practice as warranted for the treatment of specific subsets of patients with rheumatoid arthritis (RA) | 2. | Implement and/or optimize the utilization of target-based patient management within the next three months to standard patient care and optimize overall outcomes |
| 1. | Implement evidence-based guidelines into practice as warranted for the treatment of specific subsets of patients with rheumatoid arthritis (RA) |
| 2. | Implement and/or optimize the utilization of target-based patient management within the next three months to standard patient care and optimize overall outcomes |
Instructions on How to Receive Credit
- Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
- Complete the entire activity, pre/post-test and evaluation.
- After passing the post-test, print out your electronic CE certificate.
- In order to successfully complete this activity learners must achieve a minimum of 70% on the post-test.
This activity is supported by unrestricted educational grants from Bristol-Myers Squibb, Genentech, Inc., UCB, AbbVie, Inc., & Amgen.
This activity is sponsored by the Institute for Continuing Healthcare Education
Release Date: June 14, 2013
Expiration Date: June 14, 2014
Accreditation Statements
Physicians
The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Institute for Continuing Healthcare Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses
The Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity offers 0.75 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers.
Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
The Institute for Continuing Healthcare Education is approved by the California Board of Registered Nursing, Provider Number 13313. The Institute for Continuing Healthcare Education approves this activity for 1.0 contact hours.
Disclosure
Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.
Faculty
Neil Birnbaum, MD, has disclosed the following relevant financial relationships in the past 12 months: Janssen, Amgen, Pfizer,& Abbott/PE.
Vivian Bykerk, MD, has disclosed the following relevant financial relationships that have occurred within the past 12 months: Amgen, Antares, Astellas, BMS, Genentech, Merck, and UCB/A, Novartis,/SS.
Vivian Bykerk, MD, has disclosed the following relevant financial relationships that have occurred within the past 12 months: Amgen, Antares, Astellas, BMS, Genentech, Merck, and UCB/A, Novartis,/SS.
Jacqueline Fritz, RN, MSN, CNS, has disclosed the following relevant financial relationships that have occurred within the past 12 months: UCB, Novartis, Genentech, Amgen, Pfizer, Savient/SB.
Medical Writer
Anne Jacobson, MPH, CCMEP, Medical Writer, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Peer Reviewer
Stanford Peng, MD, has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of this activity.
Activity Development and Management Team
Cathy Pagano, CCMEP; Allison A. Muller, Pharm.D, D.ABAT; Scott Kober, MBA, CCMEP; April Reynolds, MS, ELS; Sandra Davidson; and Megan Small are employees of the Institute and have no relationships to disclose.
Off-label Product Disclosure
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Off-label Product Disclosure
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
COURSE VIEWING REQUIREMENTS
Google Chrome 18.0+ for Windows, Mac, or Linux
General Disclosure and Copyright Statement
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.
Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.
Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.
The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.
Google Chrome 18.0+ for Windows, Mac, or Linux
Internet Explorer 8.0+ for Windows
Firefox 13.0+ for Windows, Mac, or Linux
Safari 4.0+ for Mac
For additional technical support, please send an email to msmall@iche.eduGeneral Disclosure and Copyright Statement
The opinions expressed in this publication are those of the participating faculty and not those of the Institute for Continuing Healthcare Education (the Institute), Bristol-Myers Squibb, Genentech, AbbVie, UCB and Amgen or any manufacturers of products mentioned herein.
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.
Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.
Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.
The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.
© 2007-2024 HealthCourse, Inc. All rights reserved.
